MedPath

The effect of Topiramate in migraine improvement

Phase 2
Conditions
Migraine.
Migraine
Registration Number
IRCT201011164786N2
Lead Sponsor
Vice chancellery for research, Isfahan university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
89
Inclusion Criteria

diagnosed for migraine based on the International Headache Society (IHS) criteria by a neurologist, having headache not more than 14 days per month, a history of 3 to 12 attacks. Exclusion criteria: non-migraine headaches such as tension and sinus headaches, severe depression and a history of medical diet failure.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The clinical status of patient's migraine according to HIT6 questionnaire. Timepoint: beginning and end of the study (after 3 months). Method of measurement: history and physical exam.;The clinical status of patient's migraine according to MIDAS questionnaire. Timepoint: beginning and end of the study (after 3 months). Method of measurement: history and physical exam.
Secondary Outcome Measures
NameTimeMethod
Side effects of Topiramate in patients. Timepoint: end of the study (after 3 months). Method of measurement: history and physical exam.
© Copyright 2025. All Rights Reserved by MedPath